Predicate |
Object |
contentType |
Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial |
endingPage |
90 |
issn |
1433-0563 |
issueIdentifier |
9 |
pageRange |
1287-90 |
publicationName |
Der Urologe. Ausg. A |
startingPage |
1287 |
bibliographicCitation |
Rexer H. [Study on therapy of metastasized or locally advanced urothelial cancer: A phase III randomized clinical trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel or vinflunine in subjects with recurrent or progressive metastatic urothelial cancer (Keynote 045) - AP 48/15 der AUO]. Urologe A. 2015 Sep;54(9):1287–90. doi: 10.1007/s00120-015-3934-9. PMID: 26337168. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97c3283016b55495e65d1ee45e09bb70 |
date |
201509 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/26337168 https://doi.org/10.1007/s00120-015-3934-9 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7905 https://portal.issn.org/resource/ISSN/1433-0563 |
language |
German |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/ |
title |
[Study on therapy of metastasized or locally advanced urothelial cancer: A phase III randomized clinical trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel or vinflunine in subjects with recurrent or progressive metastatic urothelial cancer (Keynote 045) - AP 48/15 der AUO] |
discusses |
http://id.nlm.nih.gov/mesh/M0443608 http://id.nlm.nih.gov/mesh/M0288082 http://id.nlm.nih.gov/mesh/M0586473 http://id.nlm.nih.gov/mesh/M0022672 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0556300 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D061067Q000008 http://id.nlm.nih.gov/mesh/D017239Q000008 http://id.nlm.nih.gov/mesh/D043823Q000008 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D014747Q000031 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D061067Q000009 http://id.nlm.nih.gov/mesh/D017239Q000009 http://id.nlm.nih.gov/mesh/D009361 http://id.nlm.nih.gov/mesh/D014747Q000008 http://id.nlm.nih.gov/mesh/D000077143 http://id.nlm.nih.gov/mesh/D005858 http://id.nlm.nih.gov/mesh/D014747Q000009 http://id.nlm.nih.gov/mesh/D043823Q000009 http://id.nlm.nih.gov/mesh/D005060 http://id.nlm.nih.gov/mesh/D009364Q000473 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D014481 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D006801 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157688 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918295 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21874242 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9548 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118218024 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10629256 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 |